Enhancing Patient Care Through Medical Technology and Insurance Legislation
Advancements in medical technology significantly enhance patient care by enabling early disease detection and improved treatment outcomes. However, challenges related to insurance coverage can impede patients' ability to benefit from these innovations. AdvaMed is tackling these issues with its 2026 Patients First Agenda, which focuses on policies that prioritize patient-centric healthcare. By collaborating with patient advocacy groups, AdvaMed aims to address gaps in access and coverage for essential medical technologies across the United States.
In a pivotal move for 2026, AdvaMed has supported efforts leading to 10 state legislative victories aligned with its Patients First priorities. These achievements include improved access to biomarker testing, elimination of cost-sharing for cancer-related diagnostics, and expanded coverage for remote maternal health technology. These legislative advancements aim to bridge access gaps and provide vital care to patients nationwide.
Biomarker testing is crucial in personalized care, as it facilitates disease diagnosis and management through identifying specific biomarkers. Recognizing its importance, AdvaMed has backed legislation mandating insurance coverage for biomarker testing. This ensures patients receive timely and appropriate treatment. Legislative efforts in Mississippi and Tennessee have successfully required state-regulated health plans, including Medicaid and TennCare, to cover biomarker testing.
High out-of-pocket expenses often deter patients from obtaining recommended cancer diagnostics and follow-up care. AdvaMed advocates for legislation that removes financial barriers by eliminating cost-sharing elements like copays and deductibles for cancer screenings and diagnostics. In 2026, their initiatives led to legislative successes in states such as Alabama, Maine, Oregon, Utah, and Wisconsin, where cost-sharing for critical cancer diagnostics like breast, prostate, and cervical cancer screenings was prohibited.
Remote monitoring technologies are vital for maternal health, particularly in high-risk pregnancies or areas with limited healthcare access. These tools enable proactive health management by detecting potential health issues early. AdvaMed's supported legislation in Nebraska and Virginia mandates Medicaid coverage for remote maternal care technologies. This enhances support through self-monitored blood pressure services and reimbursement for remote monitoring, promoting better maternal health outcomes.
Through these legislative victories, AdvaMed's 2026 Patients First Agenda emphasizes the importance of accessible medical technologies in improving patient outcomes and supporting timely healthcare interventions. By partnering with patient advocates, AdvaMed continues to advance solutions that address coverage gaps, fostering a healthcare environment where innovative medical technologies enhance patient care across the United States.